Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (21-30 of 221) with videos related to

Pageof 23
Sort By:
Annals of Hematology|March 28, 2015
Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardizationNicholas C P Cross, Andreas Hochhaus, Martin C Müller
Leukemia Research|July 5, 2011
The two faces of myeloproliferative neoplasms: Molecular events underlying lymphoid transformationAilsa Holroyd, Nicholas C P Cross, Donald H Macdonald
Scientific Reports|January 7, 2016
Exon-centric regulation of ATM expression is population-dependent and amenable to antisense modification by pseudoexon targetingJana Kralovicova, Marcin Knut, Nicholas C P Cross, et al.
Leukemia Research|May 26, 2009
A high-throughput candidate gene mutation screen in lymphoproliferative and myeloproliferative neoplasiasSebastian Kreil, Andreas Hochhaus, Nicholas C P Cross, et al.
Clinical Chemistry|September 25, 2007
Methylation-sensitive high-resolution melting-curve analysis of the SNRPN gene as a diagnostic screen for Prader-Willi and Angelman syndromesHelen E White, Victoria J Hall, Nicholas C P Cross
Scientific Reports|May 10, 2016
Corrigendum: Exon-centric regulation of ATM expression is population-dependent and amenable to antisense modification by pseudoexon targetingJana Kralovicova, Marcin Knut, Nicholas C P Cross, et al.
British Journal of Haematology|January 10, 2012
Myeloid neoplasm with rearrangement of PDGFRA, but with no significant eosinophilia: should we broaden the World Health Organization definition of the entity?Zbigniew Rudzki, Louise Giles, Nicholas C P Cross, et al.
Blood Reviews|July 22, 2014
The future of JAK inhibition in myelofibrosis and beyondJohn O Mascarenhas, Nicholas C P Cross, Ruben A Mesa
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 14, 2006
[Application of denaturing high performance liquid chromatography to mutation detection of the c-kit gene in mastocytosis]Ling-Yan Zhang, Gong-Li Xu, Nicholas C P Cross
Haematologica|December 10, 2009
Molecular basis of myelodysplastic/myeloproliferative neoplasmsAndreas Reiter, Rosangela Invernizzi, Nicholas C P Cross, et al.
Pageof 23

Showing results (21-30 of 221) with videos related to

Sort By:
Pageof 23
Annals of Hematology|March 28, 2015
Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardizationNicholas C P Cross, Andreas Hochhaus, Martin C Müller
Leukemia Research|July 5, 2011
The two faces of myeloproliferative neoplasms: Molecular events underlying lymphoid transformationAilsa Holroyd, Nicholas C P Cross, Donald H Macdonald
Scientific Reports|January 7, 2016
Exon-centric regulation of ATM expression is population-dependent and amenable to antisense modification by pseudoexon targetingJana Kralovicova, Marcin Knut, Nicholas C P Cross, et al.
Leukemia Research|May 26, 2009
A high-throughput candidate gene mutation screen in lymphoproliferative and myeloproliferative neoplasiasSebastian Kreil, Andreas Hochhaus, Nicholas C P Cross, et al.
Clinical Chemistry|September 25, 2007
Methylation-sensitive high-resolution melting-curve analysis of the SNRPN gene as a diagnostic screen for Prader-Willi and Angelman syndromesHelen E White, Victoria J Hall, Nicholas C P Cross
Scientific Reports|May 10, 2016
Corrigendum: Exon-centric regulation of ATM expression is population-dependent and amenable to antisense modification by pseudoexon targetingJana Kralovicova, Marcin Knut, Nicholas C P Cross, et al.
British Journal of Haematology|January 10, 2012
Myeloid neoplasm with rearrangement of PDGFRA, but with no significant eosinophilia: should we broaden the World Health Organization definition of the entity?Zbigniew Rudzki, Louise Giles, Nicholas C P Cross, et al.
Blood Reviews|July 22, 2014
The future of JAK inhibition in myelofibrosis and beyondJohn O Mascarenhas, Nicholas C P Cross, Ruben A Mesa
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 14, 2006
[Application of denaturing high performance liquid chromatography to mutation detection of the c-kit gene in mastocytosis]Ling-Yan Zhang, Gong-Li Xu, Nicholas C P Cross
Haematologica|December 10, 2009
Molecular basis of myelodysplastic/myeloproliferative neoplasmsAndreas Reiter, Rosangela Invernizzi, Nicholas C P Cross, et al.
Pageof 23